Skip Navigation

JNCI Journal of the National Cancer Institute 1994 86(4):287-293; doi:10.1093/jnci/86.4.287
© 1994 by Oxford University Press
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Dellian, M.
Right arrow Articles by Goetz, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dellian, M.
Right arrow Articles by Goetz, A. E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 86, No. 4, 287-293, February 16, 1994
© 1994 Oxford University Press

High-Energy Shock Waves Enhance Hyperthermic Response of Tumors: Effects on Blood Flow, Energy Metabolism, and Tumor Growth

Marc Dellian, Stefan Walenta, Fernando Gamarra, Gerhard E. H. Kuhnle, Wolfgang Mueller-Klieser, Alwin E. Goetz*

*Correspondence to: A. E. Goetz, M.D., Institute of Anesthesiology. Klinikum Grosshadern. Ludwig-Maximilians-University. Marchioninistr. 15. D-81366 Munich, FRG.

BACKGROUND:: The ability to kill cancerous tissue by heating is often limited by heat lost to flowing blood. Recent studies demonstrate that high-energy shock waves (HESWs), when applied to solid tumors, destroy the tumor microvasculature and rapidly decrease blood flow. We hypothesized that impairment of tumor blood flow by HESWs might result in increased effectiveness of hyperthermia treatment.

PURPOSE:: The purpose of our work was to determine whether HESWs enhance the response of tumors to hyperthermia.

METHODS:: Seventy A-Mel-3 amelanotic hamster melanomas were exposed to either 700 HESWs (20 kV, 80 nanofarads), local hyperthermia (43.3 °C for 30 minutes), or a combination of both. Three, 12, or 24 hours later, tumor blood flow and adenosine triphosphate (ATP) concentrations were measured by (4-N-methy1-14C)iodoantipyrine auto-radiography and quantitative ATP imaging bioluminescence, respectively. In separate experiments, the effects of the separate and combined treatments on tumor growth were studied in 52 animals. Results: Combining HESWs and hyperthermia produced a significantly longer and more pronounced reduction of tumor and adjacent tissue perfusion than either HESWs or hyperthermia alone(P<.05). ATP concentrations were markedly reduced following HESW treatment alone and following the combined therapy compared with untreated controls (P<.05). Three hours after combined therapy, ATP concentrations were significantly below values measured after hyperthermia alone (P<.01). Tumor growth was delayed much more effectively by the combination of HESWs and hyperthermia than by either treatment alone (P<.001). Fifty-four percent of the animals receiving combined treatment showed complete local tumor cure over 52 days of observation, and 46% showed partial remission.

CONCLUSION:: The combination of HESWs and hyperthermia might be an effective new way of treating cancer, especially in patients who are not candidates for surgery.

IMPLICATIONS:: These results must be viewed cautiously, as the vasculature of human tumors seems to be less sensitive to hyperthermia than has been observed in experimental tumors. [J Natl Cancer Inst 86: 287–293, 1994]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
M. Schmitt-Sody, S. Strieth, S. Krasnici, B. Sauer, B. Schulze, M. Teifel, U. Michaelis, K. Naujoks, and M. Dellian
Neovascular Targeting Therapy: Paclitaxel Encapsulated in Cationic Liposomes Improves Antitumoral Efficacy
Clin. Cancer Res., June 1, 2003; 9(6): 2335 - 2341.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.